Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 216

1.

LDL Cholesterol Rises With BMI Only in Lean Individuals: Cross-Sectional U.S. and Spanish Representative Data.

Laclaustra M, Lopez-Garcia E, Civeira F, Garcia-Esquinas E, Graciani A, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F.

Diabetes Care. 2018 Jul 30. pii: dc180372. doi: 10.2337/dc18-0372. [Epub ahead of print]

PMID:
30061315
2.

Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial.

Mateo-Gallego R, Lacalle L, Pérez-Calahorra S, Marco-Benedí V, Recasens V, Padrón N, Lamiquiz-Moneo I, Baila-Rueda L, Jarauta E, Calmarza P, Cenarro A, Civeira F.

J Clin Lipidol. 2018 Jul 4. pii: S1933-2874(18)30275-7. doi: 10.1016/j.jacl.2018.06.017. [Epub ahead of print]

PMID:
30049591
3.

Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.

Marco-Benedí V, Lamiquiz-Moneo I, Álvarez-Sala LA, Civeira F.

Atherosclerosis. 2018 Jun 21;275:342-345. doi: 10.1016/j.atherosclerosis.2018.06.870. [Epub ahead of print]

PMID:
30015297
4.

Familial hypercholesterolemia in pediatric patients. The success begins here.

Civeira F, Pocoví M.

Clin Investig Arterioscler. 2018 Jul - Aug;30(4):179-180. doi: 10.1016/j.arteri.2018.06.001. English, Spanish. No abstract available.

PMID:
29986810
5.

Sleep duration and subclinical atherosclerosis: The Aragon Workers' Health Study.

Blasco-Colmenares E, Moreno-Franco B, Latre ML, Mur-Vispe E, Pocovi M, Jarauta E, Civeira F, Laclaustra M, Casasnovas JA, Guallar E.

Atherosclerosis. 2018 Jul;274:35-40. doi: 10.1016/j.atherosclerosis.2018.05.003. Epub 2018 May 3.

PMID:
29751282
6.

Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.

Hegele RA, Berberich AJ, Ban MR, Wang J, Digenio A, Alexander VJ, D'Erasmo L, Arca M, Jones A, Bruckert E, Stroes ES, Bergeron J, Civeira F, Witztum JL, Gaudet D.

J Clin Lipidol. 2018 Jul - Aug;12(4):920-927.e4. doi: 10.1016/j.jacl.2018.03.093. Epub 2018 Apr 4.

7.

The additive effect of adherence to multiple healthy lifestyles on subclinical atherosclerosis: Insights from the AWHS.

Uzhova I, Mateo-Gallego R, Moreno-Franco B, Molina-Montes E, Leon-Latre M, Casasnovas Lenguas JA, Civeira F, Peñalvo JL.

J Clin Lipidol. 2018 May - Jun;12(3):615-625. doi: 10.1016/j.jacl.2018.03.081. Epub 2018 Mar 28.

PMID:
29680699
8.

Dietary polyunsaturated fatty acids mediate the inverse association of stearoyl-CoA desaturase activity with the risk of fatty liver in dyslipidaemic individuals.

Amor AJ, Cofán M, Mateo-Gallego R, Cenarro A, Civeira F, Ortega E, Ros E, Sala-Vila A.

Eur J Nutr. 2018 Apr 19. doi: 10.1007/s00394-018-1691-4. [Epub ahead of print]

PMID:
29675558
9.

Association between non-cholesterol sterol concentrations and Achilles tendon thickness in patients with genetic familial hypercholesterolemia.

Baila-Rueda L, Lamiquiz-Moneo I, Jarauta E, Mateo-Gallego R, Perez-Calahorra S, Marco-Benedí V, Bea AM, Cenarro A, Civeira F.

J Transl Med. 2018 Jan 15;16(1):6. doi: 10.1186/s12967-018-1380-3.

10.

Different protein composition of low-calorie diet differently impacts adipokine profile irrespective of weight loss in overweight and obese women.

Mateo-Gallego R, Lamiquiz-Moneo I, Perez-Calahorra S, Marco-Benedí V, Bea AM, Baila-Rueda L, Laclaustra M, Peñalvo JL, Civeira F, Cenarro A.

Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):133-142. doi: 10.1016/j.numecd.2017.10.024. Epub 2017 Nov 4.

PMID:
29329923
11.

Vaccine against PCSK9: the natural strategy from passive to active immunization for the prevention of atherosclerosis.

Civeira F, Jarauta E.

J Thorac Dis. 2017 Nov;9(11):4291-4294. doi: 10.21037/jtd.2017.10.18. No abstract available.

12.

Autosomal recessive hypercholesterolemia in Spain.

Sánchez-Hernández RM, Prieto-Matos P, Civeira F, Lafuente EE, Vargas MF, Real JT, Goicoechea FG, Fuentes FJ, Pocovi M, Boronat M, Wägner AM, Masana L.

Atherosclerosis. 2018 Feb;269:1-5. doi: 10.1016/j.atherosclerosis.2017.12.006. Epub 2017 Dec 6.

PMID:
29245109
13.

Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.

Baila-Rueda L, Cenarro A, Lamiquiz-Moneo I, Perez-Calahorra S, Bea AM, Marco-Benedí V, Jarauta E, Mateo-Gallego R, Civeira F.

J Nutr Biochem. 2018 Mar;53:48-57. doi: 10.1016/j.jnutbio.2017.10.005. Epub 2017 Nov 27.

PMID:
29190549
14.

National Dyslipidemia Registry of the Spanish Arteriosclerosis Society: Current status.

Pérez-Calahorra S, Sánchez-Hernández RM, Plana N, Valdivielso P, Civeira F.

Clin Investig Arterioscler. 2017 Nov - Dec;29(6):248-253. doi: 10.1016/j.arteri.2017.09.001. Epub 2017 Nov 2. English, Spanish.

PMID:
29102473
15.

ABCG5/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols.

Lamiquiz-Moneo I, Baila-Rueda L, Bea AM, Mateo-Gallego R, Pérez-Calahorra S, Marco-Benedí V, Martín-Navarro A, Ros E, Cofán M, Rodríguez-Rey JC, Pocovi M, Cenarro A, Civeira F.

J Clin Lipidol. 2017 Nov - Dec;11(6):1432-1440.e4. doi: 10.1016/j.jacl.2017.09.005. Epub 2017 Oct 4.

PMID:
29066094
16.

Adherence to a Mediterranean diet is associated with the presence and extension of atherosclerotic plaques in middle-aged asymptomatic adults: The Aragon Workers' Health Study.

Mateo-Gallego R, Uzhova I, Moreno-Franco B, León-Latre M, Casasnovas JA, Laclaustra M, Peñalvo JL, Civeira F.

J Clin Lipidol. 2017 Nov - Dec;11(6):1372-1382.e4. doi: 10.1016/j.jacl.2017.08.007. Epub 2017 Aug 24.

PMID:
28927895
17.

Single Nucleotide Variants Associated With Polygenic Hypercholesterolemia in Families Diagnosed Clinically With Familial Hypercholesterolemia.

Lamiquiz-Moneo I, Pérez-Ruiz MR, Jarauta E, Tejedor MT, Bea AM, Mateo-Gallego R, Pérez-Calahorra S, Baila-Rueda L, Marco-Benedí V, de Castro-Orós I, Cenarro A, Civeira F.

Rev Esp Cardiol (Engl Ed). 2018 May;71(5):351-356. doi: 10.1016/j.rec.2017.07.010. Epub 2017 Sep 14. English, Spanish.

PMID:
28919240
18.

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia.

Climent E, Pérez-Calahorra S, Marco-Benedí V, Plana N, Sánchez R, Ros E, Ascaso JF, Puzo J, Almagro F, Lahoz C, Civeira F, Pedro-Botet J.

Sci Rep. 2017 Jul 17;7(1):5596. doi: 10.1038/s41598-017-06101-6.

19.

Effect of intensive LDL cholesterol lowering with PCSK9 monoclonal antibodies on tendon xanthoma regression in familial hypercholesterolemia.

Bea AM, Perez-Calahorra S, Marco-Benedi V, Lamiquiz-Moneo I, Jarauta E, Mateo-Gallego R, Civeira F.

Atherosclerosis. 2017 Aug;263:92-96. doi: 10.1016/j.atherosclerosis.2017.06.009. Epub 2017 Jun 8.

PMID:
28623742
20.

How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?

Masana L, Plana N, Pérez-Calahorra S, Ibarretxe D, Lamiquiz-Moneo I, Pedro-Botet J, Suárez-Tembra M, Valdivielso P, Ortega E, Civeira F; Dyslipidemia Registry of the Spanish Arteriosclerosis Society.

Atherosclerosis. 2017 Jul;262:107-112. doi: 10.1016/j.atherosclerosis.2017.05.013. Epub 2017 May 12.

PMID:
28531826

Supplemental Content

Loading ...
Support Center